PharmacyCodes



Tizanidinum [Inn-Latin] en es it fr

Tizanidinum [Inn-Latin] Brand names, Tizanidinum [Inn-Latin] Analogs

Tizanidinum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Tizanidinum [Inn-Latin] Chemical_Formula

C9H8ClN5S

Tizanidinum [Inn-Latin] RX_link

http://www.rxlist.com/cgi/generic/tizanidine.htm

Tizanidinum [Inn-Latin] fda sheet

Tizanidinum_[Inn-Latin] FDA

Tizanidinum [Inn-Latin] msds (material safety sheet)

Tizanidinum [Inn-Latin] Synthesis Reference

No information avaliable

Tizanidinum [Inn-Latin] Molecular Weight

253.712 g/mol

Tizanidinum [Inn-Latin] Melting Point

No information avaliable

Tizanidinum [Inn-Latin] H2O Solubility

No information avaliable

Tizanidinum [Inn-Latin] State

Solid

Tizanidinum [Inn-Latin] LogP

-1.591

Tizanidinum [Inn-Latin] Dosage Forms

Tablet

Tizanidinum [Inn-Latin] Indication

For the management of increased muscle tone associated with spasticity

Tizanidinum [Inn-Latin] Pharmacology

Tizanidine is a short-acting drug for the management of spasticity. Tizanidine is an agonist at a2-adrenergic receptor sites and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. In animal models, tizanidine has no direct effect on skeletal muscle fibers or the neuromuscular junction, and no major effect on monosynaptic spinal reflexes. The effects of tizanidine are greatest on polysynaptic pathways. The overall effect of these actions is thought to reduce facilitation of spinal motor neurons.

Tizanidinum [Inn-Latin] Absorption

No information avaliable

Tizanidinum [Inn-Latin] side effects and Toxicity

No information avaliable

Tizanidinum [Inn-Latin] Patient Information

No information avaliable

Tizanidinum [Inn-Latin] Organisms Affected

Humans and other mammals